Roche's eyesight drug may curb diabetes-related macular edema

06/28/2011 | Bloomberg

Using Roche Holding's Lucentis drug helped improve the vision and curb blood vessel abnormalities in patients with diabetes-related macular edema, experts reported at the annual meeting of the American Diabetes Association. Lucentis-treated patients were more likely to have 20/40 vision compared with those who took a placebo, experts said.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT